Effect of altered volume of distribution on aminoglycoside levels in patients in surgical intensive care
- PMID: 3813869
- DOI: 10.1001/archsurg.1987.01400140089012
Effect of altered volume of distribution on aminoglycoside levels in patients in surgical intensive care
Abstract
The apparent volume of distribution (Vd) of aminoglycosides was found to be increased in 100 patients in a surgical intensive care unit who had gram-negative pneumonia or intraabdominal sepsis and acute physiologic scores greater than 12. Following loading or maintenance doses, carefully timed blood samples were collected for measurements of serum concentrations by fluorescence polarization immunoassay. The Vd, determined by linear regression analysis of a one-compartment model using the Sawchuk-Zaske method, was 0.34 +/- 0.121 L/kg and was larger than the normal Vd of 0.20 to 0.25 L/kg, suggesting a 36% to 70% increase in extracellular fluid volume. Since there is a predictable increase in aminoglycoside Vd in the septic surgical patient, a proportionately larger aminoglycoside dosage is required initially to achieve desirable peak serum levels. Close monitoring of blood levels during maintenance dosing is suggested since dynamic changes in renal function and aminoglycoside Vd occur in the critically ill.
Similar articles
-
Altered aminoglycoside pharmacokinetics in the critically ill.Anaesth Intensive Care. 1988 Nov;16(4):418-22. doi: 10.1177/0310057X8801600406. Anaesth Intensive Care. 1988. PMID: 3232800
-
Aminoglycoside Dosing and Volume of Distribution in Critically Ill Surgery Patients.Surg Infect (Larchmt). 2020 Dec;21(10):859-864. doi: 10.1089/sur.2020.012. Epub 2020 Apr 17. Surg Infect (Larchmt). 2020. PMID: 32302517
-
Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.Drug Saf. 2013 Apr;36(4):217-30. doi: 10.1007/s40264-013-0031-0. Drug Saf. 2013. PMID: 23508544 Review.
-
Serum level monitoring of aminoglycoside antibiotics. Limitations in intensive care unit-related bacterial pneumonia.Arch Surg. 1985 Jan;120(1):99-103. doi: 10.1001/archsurg.1985.01390250087014. Arch Surg. 1985. PMID: 3966875
-
Aminoglycoside dosing considerations in intensive care unit patients.Ann Pharmacother. 1993 Mar;27(3):351-7. doi: 10.1177/106002809302700319. Ann Pharmacother. 1993. PMID: 8267695 Review.
Cited by
-
Relative pharmacokinetics of three amikacin brands in onco-hemotologic pediatric patients experiencing febrile neutropeina.Eur J Drug Metab Pharmacokinet. 2003 Jan-Mar;28(1):1-6. doi: 10.1007/BF03190860. Eur J Drug Metab Pharmacokinet. 2003. PMID: 14503658 Clinical Trial.
-
Challenges in Individualizing Drug Dosage for Intensive Care Unit Patients: Is Augmented Renal Clearance What We Really Want to Know? Some Suggested Management Approaches and Clinical Software Tools.Clin Pharmacokinet. 2016 Aug;55(8):897-905. doi: 10.1007/s40262-016-0369-4. Clin Pharmacokinet. 2016. PMID: 26914772
-
Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.Clin Pharmacokinet. 2005;44(10):1009-34. doi: 10.2165/00003088-200544100-00002. Clin Pharmacokinet. 2005. PMID: 16176116 Review.
-
Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.Clin Pharmacokinet. 2002;41(14):1135-51. doi: 10.2165/00003088-200241140-00002. Clin Pharmacokinet. 2002. PMID: 12405864 Review.
-
Variation in the pharmacokinetics of gentamicin and tobramycin in patients with pleural effusions and hypoalbuminemia.Antimicrob Agents Chemother. 1992 Mar;36(3):679-81. doi: 10.1128/AAC.36.3.679. Antimicrob Agents Chemother. 1992. PMID: 1622185 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical